Day: January 18, 2022

Íslandsbanki has today issued a EUR 300m 0.75% fixed rate senior preferred sustainable bond with a maturity of 3 years, at a spread of 83 basis points over mid-swaps. The transaction is the Bank´s second sustainable issue in Euros and was placed with 45 investors across Europe.   The bond is expected to be listed on the Irish Stock Exchange on 25 January 2022. The transaction is issued under Íslandsbanki’s GMTN Programme supported by the Bank‘s Sustainable Financing Framework, available at: https://www.islandsbanki.is/en/product/about/funding The bookrunners for the transaction were: BofA Securities, Deutsche Bank, Morgan Stanley and Nomura. Jón Guðni Ómarsson, CFO of Íslandsbanki: “We are pleased at the reception given to this second sustainable bond in Euros. The Bank has been working hard to ingrain sustainability into all aspects of...

Deployment of Blink’s EV chargers at participating GM dealerships will help support accelerated adoption of EVs Miami Beach, FL, Jan. 18, 2022 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (“EV”) charging equipment and services, announced today it is deploying EV chargers at General Motors (GM) dealerships in the U.S. and Canada. Working with leading facility solutions provider ABM, Blink is supplying its IQ 200 Level 2 chargers to participating GM dealerships. “We are proud to bring Blink’s EV charging stations to GM dealerships, providing the vital infrastructure needed to charge GM’s growing lineup of EV models,” said Michael D. Farkas, Founder & Chief Executive Officer of Blink Charging. “As transportation continues to...

BANNOCKBURN, Ill., Jan. 18, 2022 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) today announced that Cindy Miller, Chief Executive Officer, and Janet Zelenka, Chief Financial Officer and Chief Information Officer, will present and host investor meetings at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022. About StericycleStericycle, Inc., (Nasdaq: SRCL) is a U.S. based business-to-business services company and leading provider of compliance-based solutions that protects people and brands, promotes health and well-being, and safeguards the environment. Stericycle serves customers in the U.S. and 16 countries with solutions for regulated waste and compliance services, secure information destruction and patient engagement. For more information about Stericycle, please visit www.stericycle.com. FOR...

Sheridan, Wyoming, Jan. 18, 2022 (GLOBE NEWSWIRE) — Publicly-held Lee Pharmaceuticals (OTC Pink: LPHM) announces the completion of a change of control with Accelerate Global Market Solutions, Corp (AGMSC), Inc. in which AGMSC acquired control of the company’s Special Series A Preferred in a private transaction with Synergy Management and confirmation of LPHM’s business model shift to the Technology & Security sector. As part of the transaction, John Morgan was appointed as sole officer and Benjamin Berry resigned his positions. “We are currently working to update all records with the Transfer Agent, Secretary of State and OTC Markets” stated John Morgan, Chief Executive Officer. “Our strategic plans will be revealed over the coming weeks to add shareholder value and to grow the company.” Benjamin Berry has agreed to stay...

New York, NY, and Tel Aviv, ISRAEL, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released videos of recent interviews with Fox Business, Black New Channel and NewsMax. CEO Gerald Commissiong discusses strategies for improving the current COVID testing paradigm in the United States and the interplay with the effectiveness of emerging oral antiviral treatments, including Pfizer’s Paxlovid® and Merck’s Mulnupiravir® that both received Emergency Use Authorization (EUA) from the US Food & Drug Administration in December 2021, as well as Todos’ investigational oral all natural botanical drug candidate Tollovir™ that will be reading out on Phase 2 clinical trial data for the treatment of hospitalized (severe/critical)...

ATLANTA, Jan. 18, 2022 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced Manhattan Active® Supply Chain was named the Best Distribution Innovation in the 2022 Vendors in Partnership (VIP) Awards. The award recognizes the supply chain innovation that provides the largest productivity improvement, cost reduction, speed to destination, and competitive advantage in the industry. It was presented in a ceremony held in New York the week of NRF 2022, the retail industry’s largest annual conference and exposition. The VIP Awards are an annual industry celebration of the solution providers and innovations that are powering the retail ecosystem. The awards acknowledge service to the retail industry, the new ways that partnerships were formed and the recent challenges that were overcome. Launched in 2021, Manhattan...

Las Vegas, NV, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — From old-fashioned to new-fashioned, hemp has done it again and Hemp, Inc. (OTC PINK: HEMP) is right on the forefront. The Company announced it will be launching a CBDA and CBGA line of water, tinctures, gummies, capsules, and edibles, as its primary cannabinoids. With 14 years under its belt and counting, the Company has been a consistent force leading the way in the industrial hemp industry much like Oregon State University’s (OSU) recent study that “found hemp compounds could prevent a Covid-19 infection”. This not only sparked new interest in hemp compounds, it’s creating a tidal wave across the country… and who wouldn’t ride that wave? Hemp, Inc. is riding that wave. The CBDA and CBGA water, tinctures, gummies, capsules, and edibles will come in a variety...

Niagara Falls, NY , Jan. 18, 2022 (GLOBE NEWSWIRE) — Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography (“PET”) imaging systems and clinical services, is pleased to announce today that the Company has entered into a strategic business relationship with Neusoft Medical Systems for manufacturing, distribution, and continued R&D advancements of Positron’s new PET/CT nuclear imaging device. Positron, in collaboration with Neusoft, will submit a new device 510K application with the FDA for the certification of Positron’s PET/CT nuclear imaging system. Positron’s PET/CT system is based on the current NeuWise PET/CT system. The scope of the Positron/Neusoft agreement is to further develop the utilization of its PET/CT...